Restoring Sight Without Cancer

11:16–12:56 · 101s

Susan details David Sinclair’s team dropping one risky factor, using three to restore vision in blinded mice and then moving to monkeys—clearing the path to an FDA-approved human safety trial for glaucoma and NION.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.